| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Abiraterone experience in a patient with metastatic castration-resistant prostate cancer on hemodialysis
|
Karakurt Eryılmaz, Melek
|
|
2019
|
|
8 |
p. 2031-2034
|
article
|
| 2 |
A case of aseptic meningitis in a cetuximab-experienced patient with metastatic colon cancer
|
Rohrer, Chelsea L
|
|
2018
|
|
8 |
p. 632-633
|
article
|
| 3 |
A deliberative framework to identify the need for real-life evidence building of new cancer drugs after interim funding decision
|
Leung, Leanne
|
|
2018
|
|
8 |
p. 584-598
|
article
|
| 4 |
Age-dependent overall survival benefit of androgen deprivation therapy for metastatic prostate cancer
|
Keating, Matthew J
|
|
2019
|
|
8 |
p. 1927-1932
|
article
|
| 5 |
An evaluation of chemotherapy drug preparation process in hospitals in Turkey – A pilot study
|
Bayraktar-Ekincioglu, Aygin
|
|
2018
|
|
8 |
p. 563-573
|
article
|
| 6 |
Apalutamide: A new agent in the management of prostate cancer
|
May, Megan B
|
|
2019
|
|
8 |
p. 1968-1978
|
article
|
| 7 |
A review of R-DHAP administration in the outpatient setting and a case of the alternative regimen R-DHAX given outpatient for refractory diffuse large B-cell lymphoma
|
Hill, Hailey
|
|
2019
|
|
8 |
p. 2041-2044
|
article
|
| 8 |
Case report of neurotoxicity with blinatumomab and concurrent intrathecal chemotherapy in second relapse of acute lymphoblastic leukemia with central nervous system disease
|
Chen, Jason
|
|
2019
|
|
8 |
p. 2027-2030
|
article
|
| 9 |
Ceritinib: A primer for pharmacists
|
Au, Trang H
|
|
2017
|
|
8 |
p. 602-614
|
article
|
| 10 |
Comments on “Prognostic factors for survival in patients with metastatic malign melanoma treated with ipilimumab: Turkish Oncology Group study”
|
Yilmaz, Melek Tugce
|
|
2019
|
|
8 |
p. 2060-2062
|
article
|
| 11 |
Comparison of quality of life of patients on treatment with cisplatin and gemcitabine, carboplatin and gemcitabine, carboplatin and paclitaxel, carboplatin and pemetrexed for non-small cell lung cancer
|
Saranya, K
|
|
2019
|
|
8 |
p. 1853-1859
|
article
|
| 12 |
Concomitant use of levofloxacin and fluconazole leading to possible torsades de pointes
|
Tilton, Jessica J
|
|
2019
|
|
8 |
p. 2004-2006
|
article
|
| 13 |
Concurrent gastrointestinal perforation and pulmonary embolism due to bevacizumab in an adult undergoing treatment for stage IV colon cancer
|
Qureshi, Sana
|
|
2017
|
|
8 |
p. 625-628
|
article
|
| 14 |
Congratulations to the OPP Best Paper Awardees
|
|
|
2019
|
|
8 |
p. 2064
|
article
|
| 15 |
Continuous angiogenesis inhibition in the treatment for von Hippel–Lindau-related hemangioblastomas of retina and spinal cord
|
Salim, Derya Kıvrak
|
|
2019
|
|
8 |
p. 2049-2051
|
article
|
| 16 |
Dapsone and azole interactions: A clinical perspective
|
Corallo, Carmela
|
|
2018
|
|
8 |
p. 637-640
|
article
|
| 17 |
Demonstrating the value of the oncology pharmacist within the healthcare team
|
M Segal, Eve
|
|
2019
|
|
8 |
p. 1945-1967
|
article
|
| 18 |
Discontinuation of sorafenib can lead to the emergence of FLT3-ITD-positive acute myeloid leukemia
|
Kakiuchi, Seiji
|
|
2019
|
|
8 |
p. 2010-2015
|
article
|
| 19 |
Dose-related periorbital edema following sorafenib in a patient with acute myeloid leukemia
|
Freyer, Craig W
|
|
2019
|
|
8 |
p. 2035-2037
|
article
|
| 20 |
Economic sustainability of nivolumab at flat dose for second-line treatment of metastatic non-small cell lung cancer in real life
|
Giuliani, Jacopo
|
|
2019
|
|
8 |
p. 2059-2060
|
article
|
| 21 |
Effect of denosumab versus zoledronic acid on calcium levels in cancer patients with bone metastasis: A retrospective cohort study
|
Nasser, Sahar M
|
|
2019
|
|
8 |
p. 1846-1852
|
article
|
| 22 |
Evaluation of anti-infectives prescriptions in a pediatric hemato-oncological center: A retrospective study
|
Diop, Boubacar BF
|
|
2019
|
|
8 |
p. 1811-1816
|
article
|
| 23 |
Evaluation of arthralgias in adult oncology patients receiving immune checkpoint inhibitors
|
Lee, Jenessa
|
|
2019
|
|
8 |
p. 1867-1872
|
article
|
| 24 |
Evaluation of a safe handling and cytotoxic drug preparation training program for oncology pharmacy practitioners
|
Ozakin, Gozde Yesilyaprak
|
|
2019
|
|
8 |
p. 1979-1986
|
article
|
| 25 |
Evaluation of electronic health record implementation on pharmacist interventions related to oral chemotherapy management
|
Finn, Anastasia
|
|
2017
|
|
8 |
p. 563-574
|
article
|
| 26 |
Evaluation of pegfilgrastim use at an academic medical center
|
Tang, Kathy
|
|
2018
|
|
8 |
p. 604-608
|
article
|
| 27 |
Evaluation of the clinical impact of concomitant acid suppression therapy in colorectal cancer patients treated with capecitabine monotherapy
|
Rhinehart, Hannah E
|
|
2019
|
|
8 |
p. 1839-1845
|
article
|
| 28 |
FLAG/FLAG-IDA regimen for children with relapsed/refractory acute leukemia in the era of targeted novel therapies
|
Mustafa, Omima
|
|
2019
|
|
8 |
p. 1831-1838
|
article
|
| 29 |
Impact of a clinical pathway on appropriate empiric vancomycin use in cancer patients with febrile neutropenia
|
Vicente, Mildred
|
|
2017
|
|
8 |
p. 575-581
|
article
|
| 30 |
Impact of dosing frequency (once daily or twice daily) on patient adherence to oral targeted therapies for hematologic malignancies: a retrospective cohort study among managed care enrollees
|
Patel, Krish
|
|
2019
|
|
8 |
p. 1897-1906
|
article
|
| 31 |
Impact of therapeutic modalities on disease-specific survival in older adults with glioblastoma: A single-institution retrospective cohort study
|
Iskandar, Andrew S
|
|
2019
|
|
8 |
p. 1999-2003
|
article
|
| 32 |
Implementation of an online chemotherapy checking training module enhances scope of practice and ensures competency
|
Garg, Manju
|
|
2019
|
|
8 |
p. 1987-1994
|
article
|
| 33 |
Incidence and attributes of chemotherapy induced myelotoxicity, anemia and neutropenia in adults with cancer in Nepal: A cross-sectional observational study
|
Sah, Shiv K.
|
|
2019
|
|
8 |
p. 1823-1830
|
article
|
| 34 |
Late-onset Stevens–Johnson syndrome due to nivolumab use for hepatocellular carcinoma
|
Dasanu, Constantin A
|
|
2019
|
|
8 |
p. 2052-2055
|
article
|
| 35 |
Loperamide and cardiac events: Is high-dose use still safe for chemotherapy-induced diarrhea?
|
de Lemos, Mário L
|
|
2018
|
|
8 |
p. 634-636
|
article
|
| 36 |
Making moves: Transitioning R-EPOCH to the ambulatory setting
|
Martin, Allison L
|
|
2018
|
|
8 |
p. 617-622
|
article
|
| 37 |
Nivolumab-induced acute-onset type 1 diabetes mellitus as an immune-related adverse event: A case report
|
Hatakeyama, Yukihisa
|
|
2019
|
|
8 |
p. 2023-2026
|
article
|
| 38 |
Nivolumab-induced vitiligo in a metastatic melanoma patient: A case report
|
Edmondson, Lindsay A
|
|
2017
|
|
8 |
p. 629-634
|
article
|
| 39 |
Pemetrexed-induced severe rhabdomyolysis in lung cancer: A case report
|
Sullivan, Kevin
|
|
2019
|
|
8 |
p. 2007-2009
|
article
|
| 40 |
Persistently curly hair phenotype with the use of nivolumab for squamous cell lung cancer
|
Dasanu, Constantin A
|
|
2017
|
|
8 |
p. 638-640
|
article
|
| 41 |
Pharmacologic management of myelofibrosis
|
Leung, Michael
|
|
2017
|
|
8 |
p. 591-601
|
article
|
| 42 |
Plasma levels of trastuzumab in gastric cancer: Case report
|
González-García, J
|
|
2017
|
|
8 |
p. 635-637
|
article
|
| 43 |
Propofol-based balanced anesthesia is safer in pediatric radiotherapy
|
Yıldırım, İlknur
|
|
2019
|
|
8 |
p. 1891-1896
|
article
|
| 44 |
Real-world chart review study of adverse events management in patients taking tyrosine kinase inhibitors to treat metastatic renal cell carcinoma
|
Srinivas, Sandy
|
|
2018
|
|
8 |
p. 574-583
|
article
|
| 45 |
Re: Combination of radiotherapy and immunotherapy? Do timing and dose matter?
|
Ürün, Yüksel
|
|
2019
|
|
8 |
p. 2062-2063
|
article
|
| 46 |
Relative bioavailability of an extemporaneously prepared aprepitant oral suspension in healthy adults
|
Patel, Priya
|
|
2019
|
|
8 |
p. 1907-1915
|
article
|
| 47 |
Resource implications of bortezomib therapy in a large UK cohort: An evaluation study
|
Djebbari, Faouzi
|
|
2019
|
|
8 |
p. 1995-1998
|
article
|
| 48 |
Retrospective analysis of goal drug level attainment of posaconazole for invasive fungal infection prophylaxis in patients with acute myeloid leukemia pre- and post-switch to tablet formulation
|
Liebenstein, Tyler K
|
|
2018
|
|
8 |
p. 599-603
|
article
|
| 49 |
Safety and efficacy of a urine alkalinization protocol developed for high-dose methotrexate patients during intravenous bicarbonate shortage
|
Roy, Amanda M
|
|
2019
|
|
8 |
p. 1860-1866
|
article
|
| 50 |
Sarcoidosis-like syndrome and lymphadenopathy due to checkpoint inhibitors
|
Firwana, Belal
|
|
2017
|
|
8 |
p. 620-624
|
article
|
| 51 |
Severe hypersensitivity allergic reaction to filgrastim in a healthy stem cell donor
|
Doval, Divya
|
|
2019
|
|
8 |
p. 2056-2058
|
article
|
| 52 |
Severe left atrial enlargement due to carfilzomib use in multiple myeloma
|
Dasanu, Constantin A
|
|
2019
|
|
8 |
p. 2045-2048
|
article
|
| 53 |
Severe sunitinib-induced myelosuppression in a patient with a CYP 3A4 polymorphism
|
Patel, Nirav D
|
|
2018
|
|
8 |
p. 623-626
|
article
|
| 54 |
Severe warm-antibody autoimmune hemolytic anemia due to multicentric Castleman disease: Responding to rituximab
|
Iskandar, Andrew
|
|
2019
|
|
8 |
p. 2016-2018
|
article
|
| 55 |
Simulation program of a cytotoxic compounding robot for monoclonal antibodies and anti-infectious sterile drug preparation
|
Deljehier, Thomas
|
|
2019
|
|
8 |
p. 1873-1890
|
article
|
| 56 |
Sirolimus and mirabegron interaction in a hematopoietic cell transplant patient
|
Engle, Jeff A
|
|
2018
|
|
8 |
p. 627-631
|
article
|
| 57 |
Start using a checklist, PRONTO: Recommendation for a standard review process for chemotherapy orders
|
Crandell, Brian C
|
|
2018
|
|
8 |
p. 609-616
|
article
|
| 58 |
Study of cases of abiraterone discontinuation due to toxicity in pre-chemotherapy after 1 year’s experience
|
Ramudo-Cela, Luis
|
|
2017
|
|
8 |
p. 615-619
|
article
|
| 59 |
Tamoxifen-induced hepatotoxicity caused by drug interaction with direct-acting antiviral agents for hepatitis C
|
Wyffels, Klara
|
|
2019
|
|
8 |
p. 2038-2040
|
article
|
| 60 |
The impacts of a pharmacist-managed outpatient clinic and chemotherapy-directed electronic order sets for monitoring oral chemotherapy
|
Battis, Brandon
|
|
2017
|
|
8 |
p. 582-590
|
article
|
| 61 |
The role of the pharmacist in improving medication beliefs and adherence in cancer patients
|
Birand, Nevzat
|
|
2019
|
|
8 |
p. 1916-1926
|
article
|
| 62 |
Vinblastine-induced posterior reversible encephalopathy syndrome
|
Ayesh (Haj Yousef), Mahmoud H
|
|
2019
|
|
8 |
p. 2019-2022
|
article
|
| 63 |
What patient assessment skills are required by pharmacists prescribing systemic anti-cancer therapy? A consensus study
|
Allison, Jennifer
|
|
2019
|
|
8 |
p. 1933-1944
|
article
|
| 64 |
Wound healing complications with lenvatinib identified in a pharmacovigilance database
|
Cheng, Connie
|
|
2019
|
|
8 |
p. 1817-1822
|
article
|
Journal description